The quality of websites regarding statins (Preprint)

Author:

Ling Eunice,de Pieri Domenico,Loh Evenne,Scott Karen,Li Stephen,Medbury Heather

Abstract

BACKGROUND

Cardiovascular disease (CVD) represents the greatest burden of mortality worldwide and statins are the most commonly prescribed drug in its management. A wealth of information pertaining to statins and their side effects is on the internet, however, to date, no assessment of the accuracy, credibility and readability of this information has been undertaken.

OBJECTIVE

To evaluate the quality (accuracy, credibility, and readability) of websites likely to be visited by the general public undertaking a Google search of the side effects and utility of statin medications.

METHODS

Following a Google web search, we reviewed the top 20 consumer-focused websites with statins information. Website accuracy, credibility and readability were assessed based on site category (commercial, not-for-profit, media), site rank and presence or absence of the Health On the Net Code of Conduct (HONcode) seal. Accuracy and credibility were assessed following the development of checklists (with 20 and 13 items respectively). Readability was assessed using the Simple Measure of Gobbledegook scores.

RESULTS

Overall, the accuracy score was low, (x̅ =14.35 out of 20). While side effects were comprehensively covered by 70% of sites, there was little information about statin use in primary and secondary prevention. None of the websites met all criteria on the credibility checklist, (x̅ 7.8 out of 13). The median SMOG score was 9.65, with none of the websites meeting the recommended reading grade of 6, even the media websites. Websites bearing the HONcode seal were relatively more credible than those without it, scoring significantly higher (p=0.004) in credibility (x̅ = 8.9) than sites without the HONcode seal (x̅ = 6).

CONCLUSIONS

The quality of statin-related websites tended to be poor. Though the information contained was accurate, it was not comprehensive, and was presented at a reading level too difficult for the average reader to fully comprehend. As such, consumers risk being uninformed about this pharmacotherapy.

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3